Global Transfection Reagents and Equipment Market - Industry Trends and Forecast to 2030

Description

List of Tables

Global transfection reagents and equipment market is projected to register a substantial CAGR of 9.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030. Market Segmentation: Global Transfection Reagents and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagents and Equipment, Stable Transfection Reagents, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (By Type and By Industry), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Belgium, Ireland, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E, Israel, Egypt, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030

Some of the drivers that boost transfection reagents and equipment market's growth are as follows:

Rise in the prevalence of chronic diseases

Development of synthetic biology products

Market Players: Some of the major players operating in the global transfection reagents and equipment market are:

Mirus Bio LLC.

Promega Corporation

Polyplus Transfection

Bio-Rad Laboratories, Inc.

Merck KGaA

Lonza

MaxCyte, Inc.

Altogen Biosystems

SBS Genetech

FUJIFILM Irvine Scientific (A Subsidiary of FUJIFILM Holdings Corporation)

Avanti Polar Lipids (A Subsidiary of Croda International Plc)

PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.)

Cytiva

Geno Technology Inc., USA

R&D Systems, Inc.

Takara Bio Inc.

Thermofisher Scientific Inc.

Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd),

OriGene Technologies, Inc.

Applied Biological Materials Inc. (abm)

Beckman Coulter, Inc. (A Subsidiary of Danaher)

SignaGen Laboratories

Genlantis Inc.

Ginkgo Bioworks

1 INTRODUCTION 19

1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 OVERVIEW OF THE GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET 19
1.4 LIMITATIONS 23
1.5 MARKETS COVERED 23

2 MARKET SEGMENTATION 29

2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 CURRENCY AND PRICING 31
2.5 DBMR TRIPOD DATA VALIDATION MODEL 32
2.6 MULTIVARIATE MODELLING 35
2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE 35
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.9 DBMR MARKET POSITION GRID 37
2.10 MARKET APPLICATION COVERAGE GRID 38
2.11 VENDOR SHARE ANALYSIS 39
2.12 SECONDARY SOURCES 40
2.13 ASSUMPTIONS 40

3 EXECUTIVE SUMMARY 41

4 PREMIUM INSIGHT 45

4.1 PESTEL 47
4.2 PORTER'S FIVE FORCES MODEL 48

5 INDUSTRY INSIGHTS: 49

6 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, REGULATIONS 50

6.1 EUROPEAN UNION REGULATORY SCENARIO 50
6.2 U.S. REGULATORY SCENARIO 51
6.3 JAPAN REGULATORY SCENARIO 51
6.4 CHINA REGULATORY SCENARIO 52

7 MARKET OVERVIEW 54

7.1 DRIVERS 56
- 7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES 56
- 7.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS 57
- 7.1.3 GROWING DEMAND FOR CHIMERIC GENES 57
- 7.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH 58
- 7.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS 58
7.2 RESTRAINTS 59
- 7.2.1 HIGH COST OF TRANSFECTION PRODUCTS 59
- 7.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS 59
- 7.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE 60
7.3 OPPORTUNITIES 60
- 7.3.1 EXPLORATION OF EMERGING MARKET 60
- 7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 61
- 7.3.3 SURGING LEVEL OF INVESTMENT 62
7.4 CHALLENGES 62
- 7.4.1 LONG APPROVAL PROCEDURE 62
- 7.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS-ASSOCIATED TRANSFECTION 63
- 7.4.3 LACK OF TRAINED PROFESSIONALS 64

8 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS 65

8.1 OVERVIEW 66
8.2 REAGENTS & KITS 69
8.3 INSTRUMENTS 70

9 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE 72

9.1 OVERVIEW 73
9.2 RESEARCH 76
9.3 PRECLINICAL 76
9.4 CLINICAL PHASES 77
9.5 COMMERCIAL 78

10 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE 80

10.1 OVERVIEW 81
10.2 TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT 84
10.3 STABLE TRANSECTION REAGENTS AND EQUIPMENT 84

11 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY METHODS 86

11.1 OVERVIEW 87
11.2 NON-VIRAL METHODS 90
11.3 VIRAL METHODS 90

12 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE 92

12.1 OVERVIEW 93
12.2 PLASMID DNA 95
12.3 SMALL INTERFERING RNA (SIRNA) 96
12.4 PROTEINS 97
12.5 DNA OLIGONUCLEOTIDES 98
12.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS) 99
12.7 OTHERS 99

13 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM 101

13.1 OVERVIEW 102
13.2 MAMMALIAN CELLS 104
13.3 PLANTS 105
13.4 FUNGI 106
13.5 VIRUS 107
13.6 BACTERIA 108

14 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY APPLICATION 109

14.1 OVERVIEW 110
14.2 IN VITRO APPLICATION 112
- 14.2.1 IN VIVO APPLICATION 114
- 14.2.2 BIOPRODUCTION 115
- 14.2.3 OTHERS 115
- 14.2.4 SYNTHETIC BIOLOGY 116
- 14.2.5 AGRICULTURE 116
- 14.2.6 OTHERS 116

15 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER 117

15.1 OVERVIEW 118
15.2 BIOPHARMA 121
15.3 CROS 121
15.4 CMOS/CDMOS 122
15.5 ACADEMIA 123
15.6 HOSPITALS 124
15.7 CLINICAL LABS 125
15.8 OTHERS 126

16 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL 127

16.1 OVERVIEW 128
16.2 DIRECT TENDER 131
16.3 RETAIL SALES 132
16.4 OTHERS 133

17 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION 134

17.1 OVERVIEW 135
17.2 NORTH AMERICA 140
- 17.2.1 U.S. 145
- 17.2.2 CANADA 145
- 17.2.3 MEXICO 145
17.3 EUROPE 146
- 17.3.1 GERMANY 152
- 17.3.2 U.K. 152
- 17.3.3 FRANCE 152
- 17.3.4 ITALY 152
- 17.3.5 RUSSIA 152
- 17.3.6 SPAIN 152
- 17.3.7 TURKEY 152
- 17.3.8 NETHERLANDS 152
- 17.3.9 BELGIUM 152
- 17.3.10 SWITZERLAND 152
- 17.3.11 REST OF EUROPE 152
17.4 ASIA-PACIFIC 153
- 17.4.1 CHINA 158
- 17.4.2 JAPAN 158
- 17.4.3 INDIA 158
- 17.4.4 AUSTRALIA 158
- 17.4.5 SOUTH KOREA 158
- 17.4.6 SINGAPORE 158
- 17.4.7 THAILAND 158
- 17.4.8 MALAYSIA 158
- 17.4.9 INDONESIA 158
- 17.4.10 PHILIPPINES 158
- 17.4.11 REST OF ASIA-PACIFIC 158
17.5 SOUTH AMERICA 159
- 17.5.1 BRAZIL 164
- 17.5.2 ARGENTINA 164
- 17.5.3 REST OF SOUTH AMERICA 164
17.6 MIDDLE EAST AND AFRICA 165
- 17.6.1 SOUTH AFRICA 170
- 17.6.2 SAUDI ARABIA 170
- 17.6.3 U.A.E. 170
- 17.6.4 EGYPT 170
- 17.6.5 ISRAEL 170
- 17.6.6 REST OF MIDDLE EAST AND AFRICA 170

18 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, COMPANY LANDSCAPE 171

18.1 COMPANY SHARE ANALYSIS: GLOBAL 171
18.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 172
18.3 COMPANY SHARE ANALYSIS: EUROPE 173
18.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 174

19 SWOT ANALYSIS 175

20 COMPANY PROFILE 176

20.1 THERMO FISHER SCIENTIFIC INC. 176
- 20.1.1 COMPANY SNAPSHOT 176
- 20.1.2 REVENUE ANALYSIS 176
- 20.1.3 COMPANY SHARE ANALYSIS 177
- 20.1.4 PRODUCT PORTFOLIO 177
- 20.1.5 RECENT DEVELOPMENT 178
20.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD) 179
- 20.2.1 COMPANY SNAPSHOT 179
- 20.2.2 REVENUE ANALYSIS 179
- 20.2.3 COMPANY SHARE ANALYSIS 180
- 20.2.4 PRODUCT PORTFOLIO 180
- 20.2.5 RECENT DEVELOPMENT 181
20.3 PROMEGA CORPORATION 182
- 20.3.1 COMPANY SNAPSHOT 182
- 20.3.2 COMPANY SHARE ANALYSIS 182
- 20.3.3 PRODUCT PORTFOLIO 183
- 20.3.4 RECENT DEVELOPMENT 183
20.4 TAKARA BIO INC. 184
- 20.4.1 COMPANY SNAPSHOT 184
- 20.4.2 REVENUE ANALYSIS 184
- 20.4.3 COMPANY SHARE ANALYSIS 185
- 20.4.4 PRODUCT PORTFOLIO 185
- 20.4.5 RECENT DEVELOPMENT 185
20.5 BIO-RAD LABORATORIES, INC. 186
- 20.5.1 COMPANY SNAPSHOT 186
- 20.5.2 REVENUE ANANLYSIS 186
- 20.5.3 COMPANY SHARE ANALYSIS 187
- 20.5.4 PRODUCT PORTFOLIO 187
- 20.5.5 RECENT DEVELOPMENT 188
20.6 ALTOGEN BIOSYSTEMS 189
- 20.6.1 COMPANY SNAPSHOT 189
- 20.6.2 PRODUCT PORTFOLIO 189
- 20.6.3 RECENT DEVELOPMENT 190
20.7 APPLIED BIOLOGICAL MATERIALS INC. (ABM) 191
- 20.7.1 COMPANY SNAPSHOT 191
- 20.7.2 PRODUCT PORTFOLIO 191
- 20.7.3 RECENT DEVELOPMENT 191
20.8 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC) 192
- 20.8.1 COMPANY SNAPSHOT 192
- 20.8.2 REVENUE ANALYSIS 192
- 20.8.3 PRODUCT PORTFOLIO 193
- 20.8.4 RECENT DEVELOPMENT 193
20.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER) 194
- 20.9.1 COMPANY SNAPSHOT 194
- 20.9.2 PRODUCT PORTFOLIO 194
- 20.9.3 RECENT DEVELOPMENT 194
20.10 CYTIVA 195
- 20.10.1 COMPANY SNAPSHOT 195
- 20.10.2 PRODUCT PORTFOLIO 195
- 20.10.3 RECENT DEVELOPMENT 195
20.11 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION) 196
- 20.11.1 COMPANY SNAPSHOT 196
- 20.11.2 REVENUE ANANLYSIS 196
- 20.11.3 PRODUCT PORTFOLIO 197
- 20.11.4 RECENT DEVELOPMENT 197
20.12 GENLANTIS INC. 198
- 20.12.1 COMPANY SNAPSHOT 198
- 20.12.2 PRODUCT PORTFOLIO 198
- 20.12.3 RECENT DEVELOPMENT 198
20.13 GENO TECHNOLOGY INC., USA 199
- 20.13.1 COMPANY SNAPSHOT 199
- 20.13.2 PRODUCT PORTFOLIO 199
- 20.13.3 RECENT DEVELOPMENT 199
20.14 GINKGO BIOWORKS 200
- 20.14.1 COMPANY SNAPSHOT 200
- 20.14.2 PRODUCT PORTFOLIO 200
- 20.14.3 RECENT DEVELOPMENTS 200
20.15 LONZA 201
- 20.15.1 COMPANY SNAPSHOT 201
- 20.15.2 REVENUE ANANLYSIS 201
- 20.15.3 PRODUCT PORTFOLIO 202
- 20.15.4 RECENT DEVELOPMENT 202
20.16 MAXCYTE, INC. 203
- 20.16.1 COMPANY SNAPSHOT 203
- 20.16.2 REVENUE ANALYSIS 203
- 20.16.3 PRODUCT PORTFOLIO 204
- 20.16.4 RECENT DEVELOPMENT 204
20.17 MERCK KGAA 205
- 20.17.1 COMPANY SNAPSHOT 205
- 20.17.2 REVENUE ANALYSIS 205
- 20.17.3 PRODUCT PORTFOLIO 206
- 20.17.4 RECENT DEVELOPMENT 206
20.18 MIRUS BIO LLC. 207
- 20.18.1 COMPANY SNAPSHOT 207
- 20.18.2 PRODUCT PORTFOLIO 207
- 20.18.3 RECENT DEVELOPMENT 207
20.19 ORIGENE TECHNOLOGIES, INC. 209
- 20.19.1 COMPANY SNAPSHOT 209
- 20.19.2 PRODUCT PORTFOLIO 209
- 20.19.3 RECENT DEVELOPMENT 209
20.20 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.) 210
- 20.20.1 COMPANY SNAPSHOT 210
- 20.20.2 REVENUE ANALYSIS 210
- 20.20.3 PRODUCT PORTFOLIO 211
- 20.20.4 RECENT DEVELOPMENT 211

20.21 POLYPLUS TRANSFECTION 212
- 20.21.1 COMPANY SNAPSHOT 212
- 20.21.2 PRODUCT PORTFOLIO 212
- 20.21.3 RECENT DEVELOPMENT 212
20.22 R&D SYSTEMS, INC. 214
- 20.22.1 COMPANY SNAPSHOT 214
- 20.22.2 PRODUCT PORTFOLIO 214
- 20.22.3 RECENT DEVELOPMENT 214
20.23 SBS GENETECH 215
- 20.23.1 COMPANY SNAPSHOT 215
- 20.23.2 PRODUCT PORTFOLIO 215
- 20.23.3 RECENT DEVELOPMENT 215
20.24 SIGNAGEN LABORATORIES 216
- 20.24.1 COMPANY SNAPSHOT 216
- 20.24.2 PRODUCT PORTFOLIO 216
- 20.24.3 RECENT DEVELOPMENT 216

21 QUESTIONNAIRE 218

22 RELATED REPORTS 223

LIST OF TABLES

TABLE 1 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS, 2021-2030 (USD THOUSAND) 68
TABLE 2 GLOBAL REAGENT AND KITS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
TABLE 3 GLOBAL INSTRUMENTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 71
TABLE 4 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE, 2021-2030 (USD THOUSAND) 75
TABLE 5 GLOBAL RESEARCH IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
TABLE 6 GLOBAL PRECLINICAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 77
TABLE 7 GLOBAL CLINICAL PHASES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 78
TABLE 8 GLOBAL COMMERCIAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
TABLE 9 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 83
TABLE 10 GLOBAL TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 84
TABLE 11 GLOBAL STABLE TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 85
TABLE 12 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2021-2030 (USD THOUSAND) 89
TABLE 13 GLOBAL NON-VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 90
TABLE 14 GLOBAL VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 91
TABLE 15 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE, 2021-2030 (USD THOUSAND) 95
TABLE 16 GLOBAL PLASMID DNA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
TABLE 17 GLOBAL SMALL INTERFERING RNA (SIRNA) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
TABLE 18 GLOBAL PROTEINS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
TABLE 19 GLOBAL DNA OLIGONUCLEOTIDES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
TABLE 20 GLOBAL RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 99
TABLE 21 GLOBAL OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
TABLE 22 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM, 2021-2030 (USD THOUSAND) 104
TABLE 23 GLOBAL MAMMALIAN CELLS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 105
TABLE 24 GLOBAL PLANTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 106
TABLE 25 GLOBAL FUNGI IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 106
TABLE 26 GLOBAL VIRUS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 107
TABLE 27 GLOBAL BACTERIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 108
TABLE 28 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET , BY APPLICATION, 2021-2030 (USD THOUSAND) 112
TABLE 29 GLOBAL IN VITRO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 114
TABLE 30 GLOBAL IN VIVO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 115
TABLE 31 GLOBAL BIOPRODUCTION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 115
TABLE 32 GLOBAL OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 116
TABLE 33 GLOBAL APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY INDUSTRY, 2021-2030 (USD THOUSAND) 116
TABLE 34 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 120
TABLE 35 GLOBAL BIOPHARMA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 121
TABLE 36 GLOBAL CROS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 122
TABLE 37 GLOBAL CMOS/CDMOS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 123
TABLE 38 GLOBAL ACADEMIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 124
TABLE 39 GLOBAL HOSPITALS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 125
TABLE 40 GLOBAL CLINICAL LABS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 126
TABLE 41 GLOBAL OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 126
TABLE 42 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 130
TABLE 43 GLOBAL DIRECT TENDER IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 131
TABLE 44 GLOBAL RETAIL SALES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 132
TABLE 45 GLOBAL OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 133

LIST OF FIGURES

FIGURE 1 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION 29
FIGURE 2 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DATA TRIANGULATION 32
FIGURE 3 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DROC ANALYSIS 33
FIGURE 4 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 34
FIGURE 5 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS 34
FIGURE 6 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MULTIVARIATE MODELLING 35
FIGURE 7 GLOBAL TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS 36
FIGURE 8 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DBMR MARKET POSITION GRID 37
FIGURE 9 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID 38
FIGURE 10 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: VENDOR SHARE ANALYSIS 39
FIGURE 11 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION 43
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE AND ASIA-PACIFIC IS GROWING AT THE FASTEST PACE IN THE GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2022 TO 2030 44
FIGURE 13 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2022 TO 2030 45
FIGURE 14 THE TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN 2022 & 2030 45
FIGURE 15 NORTH AMERICA IS THE FASTEST GROWING MARKET IN THE GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2022 TO 2030 46
FIGURE 16 APPROVAL PROCESS FOR GENE THERAPY IN CHINA 53
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET 55
FIGURE 18 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023 66
FIGURE 19 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023-2030 (USD THOUSAND) 67
FIGURE 20 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, CAGR (2023-2030) 67
FIGURE 21 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, LIFELINE CURVE 68
FIGURE 22 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023 73
FIGURE 23 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023-2030 (USD THOUSAND) 74
FIGURE 24 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, CAGR (2023-2030) 74
FIGURE 25 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, LIFELINE CURVE 75
FIGURE 26 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023 81
FIGURE 27 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023-2030 (USD THOUSAND) 82
FIGURE 28 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, CAGR (2023-2030) 82
FIGURE 29 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE 83
FIGURE 30 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2022 87
FIGURE 31 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2023-2030 (USD THOUSAND) 88
FIGURE 32 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, CAGR (2023-2030) 88
FIGURE 33 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, LIFELINE CURVE 89
FIGURE 34 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2022 93
FIGURE 35 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2023-2030 (USD THOUSAND) 94
FIGURE 36 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, CAGR (2023-2030) 94
FIGURE 37 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, LIFELINE CURVE 95
FIGURE 38 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2022 102
FIGURE 39 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2023-2030 (USD THOUSAND) 103
FIGURE 40 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, CAGR (2023-2030) 103
FIGURE 41 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, LIFELINE CURVE 104
FIGURE 42 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2022 110
FIGURE 43 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2023-2030 (USD THOUSAND) 111
FIGURE 44 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, CAGR (2023-2030) 111
FIGURE 45 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, LIFELINE CURVE 112
FIGURE 46 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY END USER, 2022 118
FIGURE 47 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, 2023-2030 (USD THOUSAND) 119
FIGURE 48 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, CAGR (2023-2030) 119
FIGURE 49 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, LIFELINE CURVE 120
FIGURE 50 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2022 128
FIGURE 51 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 129
FIGURE 52 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 129
FIGURE 53 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 130
FIGURE 54 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022) 136
FIGURE 55 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022) 138
FIGURE 56 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030) 138
FIGURE 57 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022 & 2030) 139
FIGURE 58 GLOBAL TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030) 139
FIGURE 59 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022) 141
FIGURE 60 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022) 143
FIGURE 61 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030) 143
FIGURE 62 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022 & 2030) 144
FIGURE 63 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030) 144
FIGURE 64 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022) 147
FIGURE 65 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022) 149
FIGURE 66 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030) 149
FIGURE 67 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (202 & 2030) 150
FIGURE 68 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030) 151
FIGURE 69 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022) 154
FIGURE 70 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022) 156
FIGURE 71 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030) 156
FIGURE 72 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022 & 2030) 157
FIGURE 73 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030) 157
FIGURE 74 SOUTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022) 160
FIGURE 75 SOUTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022) 162
FIGURE 76 SOUTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030) 162
FIGURE 77 SOUTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022 & 2030) 163
FIGURE 78 SOUTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030) 163
FIGURE 79 MIDDLE EAST AND AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022) 166
FIGURE 80 MIDDLE EAST AND AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022) 168
FIGURE 81 MIDDLE EAST AND AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030) 168
FIGURE 82 MIDDLE EAST AND AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022 & 2030) 169
FIGURE 83 MIDDLE EAST AND AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030) 169

FIGURE 84 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY SHARE 2022 (%) 171
FIGURE 85 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: COMPANY SHARE 2022 (%) 172
FIGURE 86 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY SHARE 2022 (%) 173
FIGURE 87 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY SHARE 2022 (%) 174